Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

By Maeve Serino and Adam Brown Learn about what’s new and what’s coming soon in Smart Pens, automated insulin delivery, pumps, and more Diabetes technology moves fast,...
The diaTribe Foundation convenes key diabetes experts to discuss glycemic outcomes beyond A1C on July 21, 2017, in Bethesda, MD
Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure
Sanofi’s insulin adjustment app to help people with type 2 diabetes optimize once-daily long-acting basal insulin is now available for Apple and Android devices
What are the options for approximately 90,000 Animas pumpers worldwide and for others considering a new pump? What does it mean for the pump market and patient choice?
Launch expected in 2018, possibly with no fingerstick calibration. Also, a 30% smaller transmitter and a new one-button inserter. Plus, what’s the latest on Medicare?
Sanofi’s My Dose Coach app joins other insulin dosing apps recently cleared by the FDA, and new dosing tools from Novo Nordisk/Glooko and others are also in the works
How I avoid highs, prevent lows, and stop blood sugar frustration during exercise
How it works and why it could help with exercise challenges. Plus, how diaTribe readers can try it for free
Learn more about new and upcoming glucose monitoring products – what’s available now and what could be coming soon
Device Updates from Abbott, Dexcom, Insulet, Medtronic, and Tandem
Health Canada has approved the once-daily insulin for adults with type 1 and type 2 diabetes
Ease, comfort, and actionable patterns, but some challenges with insurance coverage
Dexcom CGM for Medicare shipments start with hopefully more to come, Ascencia Contour Next One meter added, and why remote monitoring is not enabled
“Adam, what do you eat when you’re on a plane?” My six go-to strategies from hundreds of flights and airports
Studies highlight reduced hypoglycemia risk for people with type 2 diabetes who switch to “next-gen” basal insulins Toujeo or Tresiba
Information about diabetes supplies for those hit by the storms and for those who can help them
Lilly announces new program, in partnership with Express Scripts, to provide insulin directly to people with diabetes and high out of pocket drug expenses
Research presented at ADA’s 2017 conference shows exciting advances in a host of diabetes drugs – including heart benefits, improved glucose control, lower cholesterol,...
How do I stay in range while sleeping?